These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 33560154)
1. Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer's Disease. Phan LMT; Hoang TX; Vo TAT; Pham HL; Le HTN; Chinnadayyala SR; Kim JY; Lee SM; Cho WW; Kim YH; Choi SH; Cho S Expert Rev Mol Diagn; 2021 Feb; 21(2):175-193. PubMed ID: 33560154 [TBL] [Abstract][Full Text] [Related]
2. Nanobiosensors for Non-Amyloidbeta-Tau Biomarkers as Advanced Reporters of Alzheimer's Disease. Phan LMT; Hoang TX; Vo TAT; Kim JY; Lee SM; Cho WW; Kim YH; Choi SH; Cho S Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33171630 [TBL] [Abstract][Full Text] [Related]
3. Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer's Disease. Sharma A; Angnes L; Sattarahmady N; Negahdary M; Heli H Biosensors (Basel); 2023 Jul; 13(7):. PubMed ID: 37504140 [TBL] [Abstract][Full Text] [Related]
4. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Prvulovic D; Hampel H Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022 [TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567 [TBL] [Abstract][Full Text] [Related]
6. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease. Koss DJ; Dubini M; Buchanan H; Hull C; Platt B Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892 [TBL] [Abstract][Full Text] [Related]
8. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies. Thal DR; Attems J; Ewers M J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313 [TBL] [Abstract][Full Text] [Related]
9. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease. Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499 [TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease. Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903 [TBL] [Abstract][Full Text] [Related]
11. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
12. Role of tau protein in Alzheimer's disease: The prime pathological player. Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025 [TBL] [Abstract][Full Text] [Related]
13. Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease. Wu XL; Piña-Crespo J; Zhang YW; Chen XC; Xu HX Chin Med J (Engl); 2017 Dec; 130(24):2978-2990. PubMed ID: 29237931 [TBL] [Abstract][Full Text] [Related]
14. Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity. Hampel H; Mitchell A; Blennow K; Frank RA; Brettschneider S; Weller L; Möller HJ J Neural Transm (Vienna); 2004 Mar; 111(3):247-72. PubMed ID: 14991453 [TBL] [Abstract][Full Text] [Related]
15. Topographical Overlapping of the Amyloid-β and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity. Hojjati SH; Feiz F; Ozoria S; Razlighi QR; J Alzheimers Dis; 2021; 83(1):407-421. PubMed ID: 34219729 [TBL] [Abstract][Full Text] [Related]
16. Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues. Majdi A; Sadigh-Eteghad S; Rahigh Aghsan S; Farajdokht F; Vatandoust SM; Namvaran A; Mahmoudi J Rev Neurosci; 2020 May; 31(4):391-413. PubMed ID: 32017704 [TBL] [Abstract][Full Text] [Related]
18. Biomarkers of Alzheimer's disease: the present and the future. Lehmann S; Delaby C; Touchon J; Hirtz C; Gabelle A Rev Neurol (Paris); 2013 Oct; 169(10):719-23. PubMed ID: 24021316 [TBL] [Abstract][Full Text] [Related]
19. Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers. Zamanian J; Khoshbin Z; Abnous K; Taghdisi SM; Hosseinzadeh H; Danesh NM Biosens Bioelectron; 2022 Feb; 197():113789. PubMed ID: 34798498 [TBL] [Abstract][Full Text] [Related]
20. Biosensing: The best alternative for conventional methods in detection of Alzheimer's disease biomarkers. Mobed A; Hasanzadeh M Int J Biol Macromol; 2020 Oct; 161():59-71. PubMed ID: 32504710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]